India-discovered levonadifloxacin & alalevonadifloxacin: A review on susceptibility testing methods, CLSI quality control and breakpoints along with a brief account of their emerging therapeutic profile as a novel standard-of-care.
Indian J Med Microbiol
; 41: 71-80, 2023.
Article
en En
| MEDLINE
| ID: mdl-36509611
Palabras clave
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Quinolonas
/
Staphylococcus aureus Resistente a Meticilina
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Indian J Med Microbiol
Asunto de la revista:
MICROBIOLOGIA
Año:
2023
Tipo del documento:
Article